ATXS
Price
$12.92
Change
+$0.01 (+0.08%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
736.97M
83 days until earnings call
Intraday BUY SELL Signals
IRON
Price
$92.44
Change
-$1.16 (-1.24%)
Updated
Dec 12, 10:57 AM (EDT)
Capitalization
3.53B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATXS vs IRON

Header iconATXS vs IRON Comparison
Open Charts ATXS vs IRONBanner chart's image
Astria Therapeutics
Price$12.92
Change+$0.01 (+0.08%)
Volume$5.26K
Capitalization736.97M
Disc Medicine
Price$92.44
Change-$1.16 (-1.24%)
Volume$200
Capitalization3.53B
ATXS vs IRON Comparison Chart in %
ATXS
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATXS vs. IRON commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and IRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ATXS: $12.91 vs. IRON: $93.60)
Brand notoriety: ATXS and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 42% vs. IRON: 111%
Market capitalization -- ATXS: $736.97M vs. IRON: $3.53B
ATXS [@Biotechnology] is valued at $736.97M. IRON’s [@Biotechnology] market capitalization is $3.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while IRON’s TA Score has 2 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 4 bearish.
  • IRON’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than IRON.

Price Growth

ATXS (@Biotechnology) experienced а -1.60% price change this week, while IRON (@Biotechnology) price change was -0.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 05, 2026.

IRON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($3.53B) has a higher market cap than ATXS($737M). IRON YTD gains are higher at: 47.634 vs. ATXS (44.407). ATXS has higher annual earnings (EBITDA): -131.42M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. ATXS (259M). ATXS has less debt than IRON: ATXS (4.77M) vs IRON (30.9M). ATXS (0) and IRON (0) have equivalent revenues.
ATXSIRONATXS / IRON
Capitalization737M3.53B21%
EBITDA-131.42M-142.42M92%
Gain YTD44.40747.63493%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M650M40%
Total Debt4.77M30.9M15%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSIRON
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signal:
Gain/Loss:
IRON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEMMX14.620.20
+1.39%
TETON Westwood Mighty Mites AAA
IRMAX10.330.09
+0.88%
Voya Russell Mid Cap Index Port A
BMGKX38.080.20
+0.53%
BlackRock Mid-Cap Growth Equity K
ETCHX45.870.15
+0.33%
Eventide Healthcare & Life Sciences C
OEPSX81.250.20
+0.25%
Oil Equipment&Svcs UltraSector Pro Svc

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with RVMD. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.81%
RVMD - IRON
57%
Loosely correlated
+0.81%
KMSTF - IRON
54%
Loosely correlated
N/A
XNCR - IRON
53%
Loosely correlated
-0.58%
APGE - IRON
52%
Loosely correlated
+0.62%
KZR - IRON
52%
Loosely correlated
-0.79%
More